The effect of dipeptidyl peptidase-4 inhibitor and glucagon-like peptide-1 receptor agonist in gestational diabetes mellitus: a systematic review.

Chen, Chengcong; Huang, Ying; Dong, Guoqing; Zeng, Yongmei; Zhou, Ziqiong

Chen, Chengcong; Huang, Ying; Dong, Guoqing; Zeng, Yongmei; Zhou, Ziqiong.

Afiliação

Chen C; Shenzhen Maternity & Child Healthcare Hospital, Shenzhen, China.
Huang Y; Faculty of Medicine, The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China.
Dong G; Section of Endocrinology, Department of Pediatrics, Shenzhen Maternity & Child Healthcare Hospital, Shenzhen, China.
Zeng Y; Shenzhen Maternity & Child Healthcare Hospital, Shenzhen, China.
Zhou Z; Obstetrics Department, Shenzhen Maternity & Child Healthcare Hospital, Shenzhen, China.

Gynecol Endocrinol ; 36(5): 375-380, 2020 May.

Article em En | MEDLINE | ID: mdl-31858859

Assuntos

Diabetes Gestacional/tratamento farmacológico; Inibidores da Dipeptidil Peptidase IV/uso terapêutico; Receptor do Peptídeo Semelhante ao Glucagon 1/agonistas; Glicemia/efeitos dos fármacos; Feminino; Humanos; Gravidez

Palavras-chave

DPP-4 inhibitor; GDM; GLP-1 receptor agonist; blood glucose; insulin resistance

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Gestacional / Inibidores da Dipeptidil Peptidase IV / Receptor do Peptídeo Semelhante ao Glucagon 1 Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Female / Humans / Pregnancy Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google